TLR2 haplotypes in the susceptibility to and severity of Chlamydia trachomatis infections in Dutch women
- PMID: 20011697
TLR2 haplotypes in the susceptibility to and severity of Chlamydia trachomatis infections in Dutch women
Abstract
Chlamydia trachomatis infections may cause several disease conditions ranging from asymptomatic infections to severe upper genital tract pathology, thereby causing significant morbidity worldwide. Remarkable interindividual differences in the clinical course of C. trachomatis infection have been observed, and are mainly based on variation in genes encoding immune-regulatory and bacteria-sensing proteins. Toll-like receptors (TLRs) are closely involved in pathogen recognition and host defense in C. trachomatis infections. The aim of this study is to assess the role of TLR2 single nucleotide polymorphisms and haplotypes in the susceptibility to, and severity of C. trachomatis infections. The study comprised a sexually transmitted disease cohort of 468 Dutch Caucasian women and a control group of 321 women. The subfertility cohort consisted of 56 women with clinically well-defined tubal pathology. The results showed no significant differences in individual TLR2 genotype frequencies in the susceptibility for C. trachomatis infections between the C. trachomatis-positive group and controls. However, haplotype 1 was statistically significant (P = 0.015) and was associated with protection against tubal pathology following C. trachomatis infection. The same haplotype was also significantly decreased (P = 0.021) in increasing severity of C. trachomatis infections (asymptomatic > symptomatic > tubal pathology) suggesting a protective effect of this haplotype against the development of late complications.
Copyright 2009 Prous Science, S.A.U. or its licensors. All rights reserved.
Similar articles
-
TLR2, TLR4 and TLR9 genotypes and haplotypes in the susceptibility to and clinical course of Chlamydia trachomatis infections in Dutch women.Pathog Dis. 2016 Feb;74(1):ftv107. doi: 10.1093/femspd/ftv107. Epub 2015 Nov 13. Pathog Dis. 2016. PMID: 26568059 Free PMC article.
-
Do host genetic traits in the bacterial sensing system play a role in the development of Chlamydia trachomatis-associated tubal pathology in subfertile women?BMC Infect Dis. 2006 Jul 21;6:122. doi: 10.1186/1471-2334-6-122. BMC Infect Dis. 2006. PMID: 16859562 Free PMC article.
-
Potential protective effect of a G>A SNP in the 3'UTR of HLA-A for Chlamydia trachomatis symptomatology and severity of infection.Pathog Dis. 2016 Mar;74(2):ftv116. doi: 10.1093/femspd/ftv116. Epub 2015 Dec 9. Pathog Dis. 2016. PMID: 26656886 Free PMC article.
-
Chlamydia trachomatis-associated tubal factor subfertility: Immunogenetic aspects and serological screening.Hum Reprod Update. 2006 Nov-Dec;12(6):719-30. doi: 10.1093/humupd/dml030. Epub 2006 Jul 10. Hum Reprod Update. 2006. PMID: 16832042 Review.
-
Identification of candidate genes using the murine model of female genital tract infection with Chlamydia trachomatis.Drugs Today (Barc). 2009 Nov;45 Suppl B:51-9. Drugs Today (Barc). 2009. PMID: 20011695 Review.
Cited by
-
TRAIL-R1 is a negative regulator of pro-inflammatory responses and modulates long-term sequelae resulting from Chlamydia trachomatis infections in humans.PLoS One. 2014 Apr 2;9(4):e93939. doi: 10.1371/journal.pone.0093939. eCollection 2014. PLoS One. 2014. PMID: 24695582 Free PMC article.
-
Conjunctival transcriptome in scarring trachoma.Infect Immun. 2011 Jan;79(1):499-511. doi: 10.1128/IAI.00888-10. Epub 2010 Oct 11. Infect Immun. 2011. PMID: 20937763 Free PMC article.
-
The Role of TLR2 in Infection and Immunity.Front Immunol. 2012 Apr 18;3:79. doi: 10.3389/fimmu.2012.00079. eCollection 2012. Front Immunol. 2012. PMID: 22566960 Free PMC article.
-
TLR2, TLR4 and TLR9 genotypes and haplotypes in the susceptibility to and clinical course of Chlamydia trachomatis infections in Dutch women.Pathog Dis. 2016 Feb;74(1):ftv107. doi: 10.1093/femspd/ftv107. Epub 2015 Nov 13. Pathog Dis. 2016. PMID: 26568059 Free PMC article.
-
A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors.Vaccine. 2011 Sep 2;29(38):6641-9. doi: 10.1016/j.vaccine.2011.06.105. Epub 2011 Jul 8. Vaccine. 2011. PMID: 21742006 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical